About Himalaya Nutravedics India
Ayurvedic & Nutraceuticals
Himalaya Nutravedics India Limited was incorporated in June 2022 and commenced manufacturing operations later that year. The company is based in Hyderabad, Telangana, and operates from its manufacturing facility at Cherlapally. Its business model combines its own branded Ayurvedic and nutraceutical products with third-party contract manufacturing. The company has expanded its market presence across 17 states and one union territory in India. Its product portfolio covers multiple dosage forms and therapeutic categories, while its stated strengths include experienced promoters and management, end-to-end execution capabilities, long-term customer relationships and quality assurance and control. :contentReference[oaicite:5]{index=5}
IPO_DETAILS_LONG: Himalaya Nutravedics India Limited is launching a 100% fresh issue of 24,99,600 equity shares at a price band of ₹100 to ₹106 per share, with a face value of ₹10 per share. The total issue size is ₹26.50 Cr at the upper price band. The IPO opens on September 22, 2026 and closes on September 24, 2026, with allotment scheduled for September 25 and listing on BSE SME scheduled for September 29, 2026. The issue proceeds are planned for working capital requirements of ₹13.75 Cr, branding, digital marketing and sales expansion of ₹7.50 Cr, and general corporate purposes. FY26 Total Income was ₹43.12 Cr compared with ₹21.00 Cr in FY25, while PAT increased to ₹7.39 Cr from ₹2.23 Cr. FY26 ROE was 63.87%, ROCE was 36.41%, RoNW was 45.12%, PAT margin was 17.16%, EBITDA margin was 18.82% and debt-to-equity was 0.31x. :contentReference[oaicite:6]{index=6}